Tag: atrial fibrillation

Wearable necklace-ECG can detect abnormal heart rhythm

A necklace that detects abnormal heart rhythm will be showcased for the first time on EHRA Essentials 4 You, a scientific platform of the...

Left atrial appendage closure associated with a decreased stroke risk in...

Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...

TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy...

A prespecified analysis of data from the AUGUSTUS study, released at late-breaking session at the Transcatheter Cardiovascular Therapeutics scientific symposium (TCT 2019; 25–29 September,...

New Liverpool Centre for Cardiovascular Science established

The Liverpool Centre for Cardiovascular Science, an alliance between academia and the NHS, was established to advance cardiovascular and stroke research and innovation locally,...

Patients with new-onset atrial fibrillation after TAVI have highest risk of...

Amit N Vora (Duke University Medical Center/the Duke Clinical Research Institute, Durham, USA) and others report in in JACC: Cardiovascular Interventions that patients who...

Short-term DAPT is feasible for patients undergoing percutaneous LAA closure

Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and others report in EuroIntervention that a strategy of six weeks’ duration of dual antiplatelet therapy (DAPT)...

New-onset atrial fibrillation after CABG significantly increases the risk of death...

New data from the EXCEL trial, which found that percutaneous coronary intervention (PCI) was non-inferior to coronary artery bypass grafting (CABG) at three years...

Apple and Stanford Medicine launch app-based arrhythmia study

Apple has launched the Apple Heart Study app, a first-of-its-kind research study using Apple Watch’s heart rate sensor to collect data on irregular heart rhythms and...

ESC 2017: Case builds for dropping aspirin from triple therapy in...

The RE-DUAL PCI trial indicates that dual therapy with the non-vitamin K antagonist oral anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim)—and not aspirin—and a P2Y12 inhibitor...

Left atrial appendage thrombus may increase the risk of stroke after...

Sonny Palmer (St Vincent’s Hospital, Melbourne, Australia) and others report in JACC: Cardiovascular Interventions that left atrial appendage thrombus, as identified with computed tomography...

Patient enrolment complete in study assessing use of dabigatran atrial fibrillation...

  Patient enrolment into the international Phase IIIb RE-DUAL PCI study is complete. The study is evaluating the safety and efficacy of dabigatran (Pradaxa, Boehringer...

St Jude Medical launches trial of Amplatzer Amulet left atrial appendage...

The St Jude Medical Amplatzer Amulet Investigational Device Exemption (IDE) trial, which will evaluate the safety and effectiveness of the company’s Amplatzer Amulet left...

ESC and EACTS launch first collaborative atrial fibrillation guidelines

The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) have been...

Rose Medical Center among first hospitals in Colorado to offer Watchman

Rose Medical Center has become one of the first hospitals in Colorado (USA) to offer patients with non-valvular atrial fibrillation percutaneous left atrial appendage closure...